To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
1-800-KARMANOS (1-800-527-6266)
An an extension of the only National Cancer Institute (NCI)-designated comprehensive cancer center in southeast Michigan, Karmanos Cancer Institute - Dearborn gives patients access to treatments exclusive to Karmanos as well as clinical trials, cancer prevention programs and multidisciplinary teams of cancer specialists — a comprehensive approach you cannot find at a community hospital.
The 5,000+ square foot space includes:
Karmanos gives you your best chance forward in the fight against cancer.
Oncology - Medical
Oncology - Gynecologic, Oncology - Surgical
Oncology - Radiation
Ear Nose & Throat (Otolaryngology), Oncology - Surgical
Oncology - Hematology, Oncology - Medical
Felicia Robinson
Karmanos Cancer Institute
Bob Costello
Marcie Paul
Patient Power What is anticipatory grief? It’s grief that can occur before the loss of a loved one. Mary Morreale, M.D. , clinical psychiatrist an...
Patient Power Nancie Petrucelli, MS, LCGC , licensed senior genetic counselor and director of the Karmanos Cancer Genetic Counseling Service , exp...
FOX 2 A researcher and his team in Spain have identified a combination of drug therapies that is showing promise in pre-clinical studies for treat...